Andy H. Vo

3.3k total citations
26 papers, 793 citations indexed

About

Andy H. Vo is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Andy H. Vo has authored 26 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Hematology and 6 papers in Cell Biology. Recurrent topics in Andy H. Vo's work include Muscle Physiology and Disorders (10 papers), Platelet Disorders and Treatments (4 papers) and Zebrafish Biomedical Research Applications (4 papers). Andy H. Vo is often cited by papers focused on Muscle Physiology and Disorders (10 papers), Platelet Disorders and Treatments (4 papers) and Zebrafish Biomedical Research Applications (4 papers). Andy H. Vo collaborates with scholars based in United States, Germany and United Kingdom. Andy H. Vo's co-authors include Elizabeth M. McNally, Alexis R. Demonbreun, Terry R. Van Vleet, Michael J. Liguori, Mohan Rao, Rishi R. Gupta, Jordan A. Shavit, Michele Hadhazy, Judy U. Earley and David Y. Barefield and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Andy H. Vo

26 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy H. Vo United States 15 511 122 84 81 81 26 793
Yann Wallez United States 14 760 1.5× 217 1.8× 45 0.5× 28 0.3× 127 1.6× 24 1.2k
Connie S. Lebakken United States 16 826 1.6× 291 2.4× 117 1.4× 35 0.4× 46 0.6× 23 1.1k
Tea Vallenius Finland 14 789 1.5× 347 2.8× 117 1.4× 33 0.4× 125 1.5× 15 1.2k
Zhenyu Ji United States 15 901 1.8× 92 0.8× 26 0.3× 50 0.6× 138 1.7× 40 1.2k
Michelle Hussain United Kingdom 4 565 1.1× 66 0.5× 66 0.8× 16 0.2× 62 0.8× 6 966
Bryan Mitton United States 16 674 1.3× 69 0.6× 282 3.4× 17 0.2× 79 1.0× 28 1.0k
Felicity Newell Australia 16 795 1.6× 108 0.9× 62 0.7× 23 0.3× 145 1.8× 29 1.3k
Sylvie Rodrigues-Ferreira France 14 445 0.9× 151 1.2× 105 1.3× 12 0.1× 168 2.1× 24 784
Ararat J. Ablooglu United States 14 424 0.8× 142 1.2× 32 0.4× 26 0.3× 31 0.4× 21 688
Angela McCahill United Kingdom 12 839 1.6× 116 1.0× 59 0.7× 11 0.1× 87 1.1× 17 1.0k

Countries citing papers authored by Andy H. Vo

Since Specialization
Citations

This map shows the geographic impact of Andy H. Vo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy H. Vo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy H. Vo more than expected).

Fields of papers citing papers by Andy H. Vo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy H. Vo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy H. Vo. The network helps show where Andy H. Vo may publish in the future.

Co-authorship network of co-authors of Andy H. Vo

This figure shows the co-authorship network connecting the top 25 collaborators of Andy H. Vo. A scholar is included among the top collaborators of Andy H. Vo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy H. Vo. Andy H. Vo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Xu, Christos Gekas, Sakina Petiwala, et al.. (2024). Building a translational cancer dependency map for The Cancer Genome Atlas. Nature Cancer. 5(8). 1176–1194. 6 indexed citations
2.
O’Brien, Joseph, GaHyun Lee, Frank Li, et al.. (2024). The super-healing MRL strain promotes muscle growth in muscular dystrophy through a regenerative extracellular matrix. JCI Insight. 9(3). 3 indexed citations
3.
Blomme, Eric A.G., Michael J. Liguori, Prathap Kumar S. Mahalingaiah, et al.. (2023). Preclinical species gene expression database: Development and meta-analysis. Frontiers in Genetics. 13. 1078050–1078050. 9 indexed citations
4.
Zeng, Zexian, Chengsheng Mao, Andy H. Vo, et al.. (2021). Deep learning for cancer type classification and driver gene identification. BMC Bioinformatics. 22(S4). 491–491. 23 indexed citations
5.
Zeng, Zexian, Andy H. Vo, Xiaoyu Li, et al.. (2020). Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer. npj Breast Cancer. 6(1). 24–24. 10 indexed citations
6.
Grosskurth, Shaun, et al.. (2020). Small RNA Sequencing to Discover Circulating MicroRNA Biomarkers of Testicular Toxicity in Dogs. International Journal of Toxicology. 40(1). 26–39. 2 indexed citations
7.
Barefield, David Y., Andy H. Vo, Anthony Gacita, et al.. (2019). Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes. JCI Insight. 4(6). 25 indexed citations
8.
Hu, Zhilian, Yang Liu, Andy H. Vo, et al.. (2019). Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia. Journal of Thrombosis and Haemostasis. 17(4). 607–617. 11 indexed citations
9.
Zeng, Zexian, Andy H. Vo, Chengsheng Mao, et al.. (2019). Cancer classification and pathway discovery using non-negative matrix factorization. Journal of Biomedical Informatics. 96. 103247–103247. 23 indexed citations
10.
Shestopalov, Ilya, Yang Liu, Andy H. Vo, et al.. (2018). Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish. Blood Advances. 2(23). 3418–3427. 12 indexed citations
11.
Wyatt, Eugene, Alexis R. Demonbreun, Megan J. Puckelwartz, et al.. (2018). Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers. JCI Insight. 3(9). 14 indexed citations
12.
Quattrocelli, Mattia, Andy H. Vo, Judy U. Earley, et al.. (2017). Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury. PLoS Genetics. 13(10). e1007070–e1007070. 23 indexed citations
13.
Hacker, Kathryn E., Catherine C. Fahey, Stephen A. Shinsky, et al.. (2016). Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation. Journal of Biological Chemistry. 291(40). 21283–21295. 54 indexed citations
14.
Williams, LM, Andrew G. McArthur, Amogelang R. Raphenya, et al.. (2016). The transcription factor, Nuclear factor, erythroid 2 (Nfe2), is a regulator of the oxidative stress response during Danio rerio development. Aquatic Toxicology. 180. 141–154. 14 indexed citations
15.
Lamar, Kay‐Marie, Sasha Bogdanovich, Quan Q. Gao, et al.. (2016). Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ. PLoS Genetics. 12(5). e1006019–e1006019. 34 indexed citations
16.
Shestopalov, Ilya, Yang Liu, Andy H. Vo, et al.. (2016). Nfe2 Is Dispensable for Early, but Required for Adult Thrombocyte Formation and Function in Zebrafish. Blood. 128(22). 2534–2534. 1 indexed citations
17.
Vo, Andy H. & Elizabeth M. McNally. (2015). Modifier genes and their effect on Duchenne muscular dystrophy. Current Opinion in Neurology. 28(5). 528–534. 40 indexed citations
18.
Swaggart, Kayleigh A., Alexis R. Demonbreun, Andy H. Vo, et al.. (2014). Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair. Proceedings of the National Academy of Sciences. 111(16). 6004–6009. 111 indexed citations
19.
Vo, Andy H., et al.. (2013). Loss of Fibrinogen in Zebrafish Results in Symptoms Consistent with Human Hypofibrinogenemia. PLoS ONE. 8(9). e74682–e74682. 44 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026